T1	Concept 72 81	2019-nCoV
T2	Concept 115 122	clade 1
T3	Concept 131 143	other clades
T4	Action 93 106	recombination
R1	subject Arg1:T4 Arg2:T2	
R2	target Arg1:T4 Arg2:T3	
R3	causes Arg1:T4 Arg2:T1	
T5	Action 82 87	arose
R4	subject Arg1:T5 Arg2:T1	
R5	in-context Arg1:T5 Arg2:T4	
T7	Concept 632 645	pGKL plasmids
T8	Action 621 628	encoded
R6	subject Arg1:T8 Arg2:T7	
T9	Action 649 659	translated
T10	Concept 683 690	pathway
T11	Concept 667 682	cap-independent
R7	has-property Arg1:T10 Arg2:T11	
T6	Concept 615 620	toxin
T12	Concept 608 614	Killer
R8	has-property Arg1:T6 Arg2:T12	
R9	target Arg1:T8 Arg2:T6	
R10	target Arg1:T9 Arg2:T6	
R11	subject Arg1:T9 Arg2:T10	
T13	Concept 435 440	sugar
T14	Concept 422 434	concentrated
R12	has-property Arg1:T13 Arg2:T14	
T15	Action 453 457	rare
R13	subject Arg1:T15 Arg2:T13	
T16	Concept 466 472	niches
T17	Concept 461 465	wild
R14	has-property Arg1:T16 Arg2:T17	
R15	target Arg1:T15 Arg2:T16	
T18	Action 477 488	competition
T19	Concept 499 505	fierce
R16	has-property Arg1:T18 Arg2:T19	
T20	Concept 493 495	it
R17	target Arg1:T18 Arg2:T20	
*	same-as T13 T20
T21	Concept 512 526	concentrations
T22	Action 545 551	exceed
A1	Negated T22
T23	Concept 556 560	0.5%
T24	Concept 561 570	threshold
T25	Concept 586 598	fermentation
T26	Concept 580 585	sugar
T27	Action 599 607	kicks in
R18	has-property Arg1:T26 Arg2:T25	
R19	subject Arg1:T27 Arg2:T25	
R20	in-time Arg1:T22 Arg2:T27	
R21	has-property Arg1:T24 Arg2:T23	
R22	target Arg1:T22 Arg2:T24	
R23	subject Arg1:T22 Arg2:T21	
R24	has-property Arg1:T13 Arg2:T21	
T28	Concept 24 46	receptor assay results
T29	Action 58 66	possible
R25	subject Arg1:T29 Arg2:T28	
R26	target Arg1:T29 Arg2:T5	
T30	Concept 154 163	principle
T31	Concept 146 153	similar
R27	has-property Arg1:T30 Arg2:T31	
T32	Concept 180 191	contraction
T33	Concept 167 179	antagonistic
R28	has-property Arg1:T32 Arg2:T33	
R29	has-property Arg1:T32 Arg2:T30	
T34	Concept 223 231	families
T35	Concept 235 241	fibers
T36	Concept 198 222	perpendicularly oriented
R30	has-property Arg1:T34 Arg2:T36	
R31	in-place Arg1:T32 Arg2:T34	
R32	has-part Arg1:T34 Arg2:T35	
T37	Action 248 252	work
R33	subject Arg1:T37 Arg2:T32	
T38	Concept 260 278	sub-cellualr level
R34	in-place Arg1:T37 Arg2:T38	
T39	Concept 725 734	2019-nCoV
T40	Action 760 771	transmitted
T41	Concept 777 782	human
R35	subject Arg1:T40 Arg2:T41	
R36	target Arg1:T40 Arg2:T39	
T42	Concept 786 791	human
R37	in-place Arg1:T40 Arg2:T42	
T43	Action 691 700	Comparing
T44	Concept 706 714	SARS-CoV
T45	Concept 719 723	MERS
R38	subject Arg1:T43 Arg2:T39	
R39	target Arg1:T43 Arg2:T44	
R40	target Arg1:T43 Arg2:T45	
T46	Action 793 802	spreading
R41	subject Arg1:T46 Arg2:T39	
T47	Concept 815 824	countries
T48	Concept 806 814	multiple
T49	Concept 829 836	regions
R42	in-place Arg1:T46 Arg2:T49	
R43	in-place Arg1:T46 Arg2:T47	
R44	has-property Arg1:T47 Arg2:T48	
R45	has-property Arg1:T49 Arg2:T48	
T50	Action 841 848	leading
R46	subject Arg1:T50 Arg2:T46	
T51	Action 860 871	declaration
T52	Concept 856 859	WHO
R47	subject Arg1:T51 Arg2:T52	
R48	target Arg1:T50 Arg2:T51	
T53	Concept 891 900	Emergency
R49	target Arg1:T51 Arg2:T53	
T54	Concept 884 890	Health
T55	Concept 877 883	Public
R50	has-property Arg1:T54 Arg2:T55	
R51	in-context Arg1:T53 Arg2:T54	
T56	Concept 904 917	International
T57	Action 918 925	Concern
R52	subject Arg1:T57 Arg2:T53	
R53	target Arg1:T57 Arg2:T56	
R54	has-property Arg1:T57 Arg2:T56	
T58	Concept 326 334	dynamics
T59	Concept 318 325	protein
R55	has-property Arg1:T59 Arg2:T58	
T60	Concept 312 317	motor
T61	Concept 299 311	antagonistic
R56	has-property Arg1:T60 Arg2:T61	
R57	has-property Arg1:T59 Arg2:T60	
T62	Concept 355 365	structures
R58	in-place Arg1:T58 Arg2:T62	
T63	Concept 350 354	ring
T64	Concept 338 349	contractile
R59	has-property Arg1:T62 Arg2:T63	
R60	has-property Arg1:T62 Arg2:T64	
T65	Concept 379 383	cell
T66	Concept 384 392	division
T67	Concept 397 408	development
R61	has-property Arg1:T65 Arg2:T66	
R62	has-property Arg1:T65 Arg2:T67	
R63	in-context Arg1:T58 Arg2:T66	
R64	in-context Arg1:T58 Arg2:T67	
R65	is-a Arg1:T58 Arg2:T32	
